WFDC2 and non-small cell lung carcinoma: HE4 was found to be raised in 73% (11/15) of all malignancies diagnosed in the primary care group and was raised in isolation in 47%, particularly in the non-small cell lung cancers and transitional cell renal cancer, which is similar to previous reports [31].